BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +9 vs. Q2 2025
- Shares held
- 56.8M
- +40.3M (+244.1%) vs. Q2 2025
- Total value
- $657.5M
- +$482.1M (+274.8%) vs. Q2 2025
- New holders
- 24
- 10 more added
- Sold out
- 15
- 7 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 17,878,594 | $207.0M | 14.29% | +14,969,594+514.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 4,885,446 | $56.6M | 0.87% | +4,885,446 | New |
| Omega Fund Management, LLC | 3,289,661 | $38.1M | 17.13% | +3,289,661 | New |
| Wellington Management Group LLP | 2,961,263 | $34.3M | 0.01% | +2,776,673+1,504.2% | Added |
| EcoR1 Capital, LLC | 2,823,126 | $32.7M | 1.57% | +2,823,126 | New |
| Alphabet Inc. | 2,823,126 | $32.7M | 1.36% | +2,823,126 | New |
| Enavate Sciences GP, LLC | 2,626,946 | $30.4M | 9.29% | +2,626,946 | New |
| Citadel Advisors LLC | 2,538,141 | $29.4M | 0.02% | +1,110,940+77.8% | Added |
| BlackRock, Inc. | 2,048,552 | $23.7M | 0.00% | +549,687+36.7% | Added |
| Novo Holdings A/S | 1,961,317 | $22.7M | 1.46% | +1,961,317 | New |
| Paradigm Biocapital Advisors LP | 1,866,141 | $21.6M | 0.64% | +1,866,141 | New |
| Adage Capital Partners GP, L.L.C. | 1,487,621 | $17.2M | 0.03% | +87,621+6.3% | Added |
| Eventide Asset Management, LLC | 1,082,362 | $12.4M | 0.20% | +1,082,362 | New |
| Laurion Capital Management LP | 1,045,800 | $12.1M | 1.65% | +745,800+248.6% | Added |
| Octagon Capital Advisors LP | 1,043,110 | $12.1M | 1.89% | +793,110+317.2% | Added |
| Price T Rowe Associates Inc | 885,042 | $10.2M | 0.00% | −186,508−17.4% | Reduced |
| Vanguard Group Inc | 647,599 | $7.50M | 0.00% | +647,599 | New |
| Aisling Capital Management LP | 564,625 | $6.54M | 1.43% | +564,625 | New |
| Geode Capital Management, LLC | 541,602 | $6.27M | 0.00% | +528,274+3,963.6% | Added |
| ADAR1 Capital Management, LLC | 501,228 | $5.80M | 0.57% | +58,613+13.2% | Added |
| Silverarc Capital Management, LLC | 457,414 | $5.30M | 0.77% | −155,979−25.4% | Reduced |
| Armistice Capital, LLC | 412,000 | $4.77M | 0.15% | +412,000 | New |
| Millennium Management LLC | 369,563 | $4.06M | 0.00% | −527,688−58.8% | Reduced |
| Casdin Capital, LLC | 282,312 | $3.27M | 0.27% | +282,312 | New |
| Charles Schwab Investment Management Inc | 279,350 | $3.23M | 0.00% | +279,350 | New |
| Ikarian Capital, LLC | 245,231 | $2.84M | 0.64% | +245,231 | New |
| StemPoint Capital LP | 186,614 | $2.16M | 0.44% | −129,198−40.9% | Reduced |
| State Street Corp | 176,695 | $2.05M | 0.00% | +176,695 | New |
| FMR LLC | 162,077 | $1.88M | 0.00% | +162,077 | New |
| Sio Capital Management, LLC | 130,628 | $1.51M | 0.38% | +130,628 | New |
| TD Asset Management Inc | 130,062 | $1.51M | 0.00% | −14,710−10.2% | Reduced |
| Woodline Partners LP | 103,707 | $1.20M | 0.01% | +460+0.4% | Added |
| Moore Capital Management, LP | 100,000 | $1.16M | 0.02% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 96,551 | $1.12M | 0.03% | +96,551 | New |
| Northern Trust Corp | 95,957 | $1.11M | 0.00% | +95,957 | New |
| UBS Group AG | 52,226 | $604.8K | 0.00% | −16,308−23.8% | Reduced |
| XTX Topco Ltd | 23,384 | $270.8K | 0.01% | +23,384 | New |
| China Universal Asset Management Co., Ltd. | 5,000 | $57.9K | 0.00% | +5,000 | New |
| Bank of America Corp | 1,329 | $15.4K | 0.00% | +1,329 | New |
| Morgan Stanley | 861 | $9.97K | 0.00% | +861 | New |
| FNY Investment Advisers, LLC | 100 | $1.00K | 0.00% | −27,084−99.6% | Reduced |
| Royal Bank of Canada | 16 | $0 | 0.00% | +16 | New |
| Sculptor Capital LP | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| Harraden Circle Investments, LLC | 0 | $0 | 0.00% | −569,831−100.0% | Sold out |
| Berkley W R Corp | 0 | $0 | 0.00% | −445,195−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −444,377−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −398,000−100.0% | Sold out |
| Decagon Asset Management LLP | 0 | $0 | 0.00% | −348,223−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −292,338−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −210,125−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −187,257−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −108,300−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −29,381−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |